Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes
Yong Zhang,1 Kaisa Cui,2 Yaoxiang Yang,3 Bingxin Liu,4 Minzheng Zhu,1 Hanqing Chen,1 Chong Zhao,1 Youlian Zhou,1 Yuqiang Nie1 1Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, People...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-07-01
|
| Series: | Journal of Hepatocellular Carcinoma |
| Subjects: | |
| Online Access: | https://www.dovepress.com/infiltration-of-a-unique-cd8cd274-cell-subgroup-in-hepatocellular-carc-peer-reviewed-fulltext-article-JHC |
| _version_ | 1797784190493655040 |
|---|---|
| author | Zhang Y Cui K Yang Y Liu B Zhu M Chen H Zhao C Zhou Y Nie Y |
| author_facet | Zhang Y Cui K Yang Y Liu B Zhu M Chen H Zhao C Zhou Y Nie Y |
| author_sort | Zhang Y |
| collection | DOAJ |
| description | Yong Zhang,1 Kaisa Cui,2 Yaoxiang Yang,3 Bingxin Liu,4 Minzheng Zhu,1 Hanqing Chen,1 Chong Zhao,1 Youlian Zhou,1 Yuqiang Nie1 1Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, People’s Republic of China; 2Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214062, People’s Republic of China; 3Department of Pathology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, People’s Republic of China; 4The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, People’s Republic of ChinaCorrespondence: Yuqiang Nie; Youlian Zhou, Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road 1, Yuexiu District, Guangzhou, Guangdong, 510006, People’s Republic of China, Tel/Fax +86 20 81048888, Email eynieyuqiang@scut.edu.cn; eyyoulianzhou@scut.edu.cnIntroduction: Immune checkpoint (IC) inhibitor-related immunotherapies have attracted considerable attention in hepatocellular carcinoma (HCC). High IC expression and high tumor infiltrating lymphocyte levels are the current indicators of sensitivity to IC inhibitors. Thus, it is imperative to apply precision medicine strategies for patient selection.Methods: Six independent HCC cohorts were used for analysis at the single-cell and tissue levels. Multiplex immunofluorescence and immunochemistry staining assays were used to validate our results. A series of methodologies were used for immune-related evaluations.Results: Herein, we uncovered a unique CD8+CD274+ cell subpopulation that is associated with tumor progression and poor survival in HCC at the single-cell level. We assessed this subset at the tissue level and found that the prognostic significance of CD274 is dependent on CD8A expression in HCC. Subsequently, we identified a unique high-risk subpopulation that showed high CD8A expression coupled with intense CD274 expression in multiple HCC cohorts. CD8AHighCD274High* subgroup was correlated with malignant indexes and remained an independent prognostic factor when considering the influence of these indexes. Molecular characteristic analyses showed that the CD8AHighCD274High* subgroup harbored more mutations, had higher immune response activity and presented enrichment of cancer-related biological processes. Moreover, this high-risk subpopulation in HCC was characterized by high immune cell infiltration, low tumor purity, and enrichment of cancer-related signatures. Finally, cases with this phenotype demonstrated higher immunomodulator and IC levels and greater sensitivity to IC inhibitors.Conclusion: Our findings illustrate that some HCC patients may have a poor prognosis despite high CD8+ T-cell infiltration. These patients would probably benefit from IC inhibitor-based combination treatment.Keywords: hepatocellular carcinoma, CD8A, CD274, molecular subtype, tumor microenvironment, immune overdrive |
| first_indexed | 2024-03-13T00:36:26Z |
| format | Article |
| id | doaj.art-0a53309071874db39e805da2ffa45a16 |
| institution | Directory Open Access Journal |
| issn | 2253-5969 |
| language | English |
| last_indexed | 2024-03-13T00:36:26Z |
| publishDate | 2023-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Hepatocellular Carcinoma |
| spelling | doaj.art-0a53309071874db39e805da2ffa45a162023-07-09T19:03:31ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692023-07-01Volume 101051106785003Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical OutcomesZhang YCui KYang YLiu BZhu MChen HZhao CZhou YNie YYong Zhang,1 Kaisa Cui,2 Yaoxiang Yang,3 Bingxin Liu,4 Minzheng Zhu,1 Hanqing Chen,1 Chong Zhao,1 Youlian Zhou,1 Yuqiang Nie1 1Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, People’s Republic of China; 2Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214062, People’s Republic of China; 3Department of Pathology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, People’s Republic of China; 4The Key Laboratory of Modern Toxicology of Ministry of Education, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, 211166, People’s Republic of ChinaCorrespondence: Yuqiang Nie; Youlian Zhou, Department of Gastroenterology and Hepatology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road 1, Yuexiu District, Guangzhou, Guangdong, 510006, People’s Republic of China, Tel/Fax +86 20 81048888, Email eynieyuqiang@scut.edu.cn; eyyoulianzhou@scut.edu.cnIntroduction: Immune checkpoint (IC) inhibitor-related immunotherapies have attracted considerable attention in hepatocellular carcinoma (HCC). High IC expression and high tumor infiltrating lymphocyte levels are the current indicators of sensitivity to IC inhibitors. Thus, it is imperative to apply precision medicine strategies for patient selection.Methods: Six independent HCC cohorts were used for analysis at the single-cell and tissue levels. Multiplex immunofluorescence and immunochemistry staining assays were used to validate our results. A series of methodologies were used for immune-related evaluations.Results: Herein, we uncovered a unique CD8+CD274+ cell subpopulation that is associated with tumor progression and poor survival in HCC at the single-cell level. We assessed this subset at the tissue level and found that the prognostic significance of CD274 is dependent on CD8A expression in HCC. Subsequently, we identified a unique high-risk subpopulation that showed high CD8A expression coupled with intense CD274 expression in multiple HCC cohorts. CD8AHighCD274High* subgroup was correlated with malignant indexes and remained an independent prognostic factor when considering the influence of these indexes. Molecular characteristic analyses showed that the CD8AHighCD274High* subgroup harbored more mutations, had higher immune response activity and presented enrichment of cancer-related biological processes. Moreover, this high-risk subpopulation in HCC was characterized by high immune cell infiltration, low tumor purity, and enrichment of cancer-related signatures. Finally, cases with this phenotype demonstrated higher immunomodulator and IC levels and greater sensitivity to IC inhibitors.Conclusion: Our findings illustrate that some HCC patients may have a poor prognosis despite high CD8+ T-cell infiltration. These patients would probably benefit from IC inhibitor-based combination treatment.Keywords: hepatocellular carcinoma, CD8A, CD274, molecular subtype, tumor microenvironment, immune overdrivehttps://www.dovepress.com/infiltration-of-a-unique-cd8cd274-cell-subgroup-in-hepatocellular-carc-peer-reviewed-fulltext-article-JHChepatocellular carcinomacd8acd274molecular subtypetumor microenvironmentimmune overdrive. |
| spellingShingle | Zhang Y Cui K Yang Y Liu B Zhu M Chen H Zhao C Zhou Y Nie Y Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes Journal of Hepatocellular Carcinoma hepatocellular carcinoma cd8a cd274 molecular subtype tumor microenvironment immune overdrive. |
| title | Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes |
| title_full | Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes |
| title_fullStr | Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes |
| title_full_unstemmed | Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes |
| title_short | Infiltration of a Unique CD8+CD274+ Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes |
| title_sort | infiltration of a unique cd8 cd274 cell subgroup in hepatocellular carcinoma is associated with poor clinical outcomes |
| topic | hepatocellular carcinoma cd8a cd274 molecular subtype tumor microenvironment immune overdrive. |
| url | https://www.dovepress.com/infiltration-of-a-unique-cd8cd274-cell-subgroup-in-hepatocellular-carc-peer-reviewed-fulltext-article-JHC |
| work_keys_str_mv | AT zhangy infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT cuik infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT yangy infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT liub infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT zhum infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT chenh infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT zhaoc infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT zhouy infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes AT niey infiltrationofauniquecd8cd274cellsubgroupinhepatocellularcarcinomaisassociatedwithpoorclinicaloutcomes |